Abstract
Novel, mesalazine, metronidazole conjugates 6a-e with amino acid linkers were synthesized utilizing benzotriazole chemistry. Biological data acquired for all the novel bis-conjugates showed (a) some bis-conjugates exhibit comparable anti-inflammatory activity with parent drugs and (b) the potent bis-conjugates show no visible stomach lesions. 3D-pharmacophore and 2D-QSAR modeling support the observed bio-properties.
Keywords:
Amino acids; Anti-inflammatory; Conjugates; Mesalazine; Metronidazole; QSAR.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Inflammatory Agents / adverse effects
-
Anti-Inflammatory Agents / chemistry
-
Anti-Inflammatory Agents / pharmacology*
-
Indomethacin / toxicity
-
Mesalamine / adverse effects
-
Mesalamine / chemistry
-
Mesalamine / pharmacology*
-
Metronidazole / adverse effects
-
Metronidazole / chemistry
-
Metronidazole / pharmacology*
-
Mice
-
Molecular Structure
-
Quantitative Structure-Activity Relationship
-
Stomach Ulcer / chemically induced
Substances
-
Anti-Inflammatory Agents
-
Metronidazole
-
Mesalamine
-
Indomethacin